Ossium Health Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 103

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 26

Ossium Health General Information

Description

Developer of stem cell-based therapies designed to improve the health, vitality, and longevity of human beings through bioengineering. The company's therapies cure leukemia and other blood diseases, improve organ transplantation, treat radiation poisoning, and heal tissue damage, enabling healthcare professionals to improve a new paradigm for cell therapy development by bringing the deceased donor transplant ecosystem into the fight against diseases of the blood and immune systems.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 80 Tehama Street
  • San Francisco, CA 94105
  • United States
+1 (415)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 80 Tehama Street
  • San Francisco, CA 94105
  • United States
+1 (415)

Ossium Health Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ossium Health Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Secondary Transaction - Private 01-Apr-2026 Completed Generating Revenue
12. Later Stage VC 01-Feb-2026 Completed Generating Revenue
11. Later Stage VC (Series C) 25-Jul-2023 Completed Generating Revenue
10. Grant 28-Apr-2023 Completed Generating Revenue
9. Grant 20-Sep-2021 Completed Clinical Trials - Phase 2
8. Later Stage VC (Series B) 18-Mar-2021 Completed Clinical Trials - Phase 2
7. Grant 18-Aug-2020 Completed Clinical Trials - Phase 2
6. Grant 08-May-2019 Completed Clinical Trials - Phase 2
5. Early Stage VC (Series A) 24-May-2018 $10.4M $10.4M Completed Clinical Trials - Phase 2
4. Grant 19-Apr-2018 $573K Completed Clinical Trials - Phase 2
To view Ossium Health’s complete valuation and funding history, request access »

Ossium Health Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B-3 Prime
Series B-2 Prime
Series B-1 Prime
Series B Prime
Series B-3
Series B-2
Series B-1
Series B 155,038,754 $0.000001 8% $0.32 $0.32 $0.32 18.12%
Series A-3 Prime 21,930,077 $0.000001 8% $0.1 $0.1 $0.1 2.56%
To view Ossium Health’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Ossium Health Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of stem cell-based therapies designed to improve the health, vitality, and longevity of human beings through b
Drug Discovery
San Francisco, CA
103 As of 2026

Newtown, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ossium Health Competitors (1)

One of Ossium Health’s competitors is Onconova Therapeutics, a Formerly VC-backed company based in Newtown, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Onconova Therapeutics Formerly VC-backed Newtown, PA
You’re viewing 1 of 1 competitors. Get the full list »

Ossium Health Patents

Ossium Health Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026170062-A1 Potency assay matrix for establishing consistency of manufactured cells Pending 06-Feb-2025
WO-2025170935-A1 Systems and methods for extraction and cryopreservation of bone marrow Pending 05-Feb-2024
EP-4794743-A1 Compositions and methods comprising tissue implants Pending 20-Oct-2023
US-20260248858-A1 Compositions and methods comprising tissue implants Pending 20-Oct-2023
WO-2025085793-A1 Compositions and methods comprising tissue implants Inactive 20-Oct-2023 A61L27/3608
To view Ossium Health’s complete patent history, request access »

Ossium Health Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ossium Health Investors (26)

Investor Name Investor Type Holding Investor Since Participating Rounds
FemHealth Ventures Venture Capital Minority
Alumni Ventures Venture Capital Minority
CPMG Growth/Expansion Minority
California Institute for Regenerative Medicine Government
National Institute of General Medical Sciences Government
You’re viewing 5 of 26 investors. Get the full list »

Ossium Health FAQs

  • When was Ossium Health founded?

    Ossium Health was founded in 2016.

  • Where is Ossium Health headquartered?

    Ossium Health is headquartered in San Francisco, CA.

  • What is the size of Ossium Health?

    Ossium Health has 103 total employees.

  • What industry is Ossium Health in?

    Ossium Health’s primary industry is Drug Discovery.

  • Is Ossium Health a private or public company?

    Ossium Health is a Private company.

  • What is Ossium Health’s current revenue?

    The current revenue for Ossium Health is .

  • How much funding has Ossium Health raised over time?

    Ossium Health has raised $126M.

  • Who are Ossium Health’s investors?

    FemHealth Ventures, Alumni Ventures, CPMG, California Institute for Regenerative Medicine, and National Institute of General Medical Sciences are 5 of 26 investors who have invested in Ossium Health.

  • Who are Ossium Health’s competitors?

    Onconova Therapeutics is a competitor of Ossium Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process